Post-traumatic stress disorder can affect how a person feels, thinks, sleeps, connects, and moves through daily life. According to the VA National Center for PTSD, millions of Americans live with PTSD in a given year, and many continue to experience symptoms even after trying therapy, medication, or other forms of support.
At Revitalizing Therapies in Kissimmee, we offer ketamine therapy as part of a compassionate, individualized care model for appropriate candidates. Ketamine is not FDA-approved for PTSD; its use for psychiatric conditions is considered off-label. For some patients, however, it may be an option worth discussing when standard approaches have not brought enough relief.
Understanding PTSD and Why Standard Treatments May Not Be Enough
PTSD is not simply a stress response that fades with time. It can involve lasting changes in how the brain and nervous system process threat, memory, emotion, and safety. Symptoms may include intrusive memories, nightmares, avoidance, emotional numbing, irritability, hypervigilance, sleep disruption, and difficulty feeling present in daily life.
Evidence-based treatments such as prolonged exposure therapy, cognitive processing therapy, EMDR, and certain medications help many people with PTSD. But not every patient responds fully. Some people continue to feel stuck in fear, avoidance, or emotional shutdown despite doing the work and following the recommended steps.
At Revitalizing Therapies, rethinking mental health means being willing to look beyond a one-size-fits-all protocol. Our team helps patients explore PTSD treatment options with care, honesty, and respect for the complexity of trauma.
Why Ketamine Is Being Studied for PTSD
Ketamine works through a different pathway than many traditional psychiatric medications. Rather than primarily targeting serotonin or norepinephrine, ketamine interacts with the glutamate system, including NMDA receptor activity. Researchers are studying whether this mechanism may help support neuroplasticity, emotional processing, and symptom relief in certain psychiatric conditions.
Early clinical research has examined ketamine for PTSD, including randomized studies of single and repeated infusions. These studies suggest ketamine may reduce PTSD symptom severity for some patients, but the evidence is still developing, and results vary by individual.
That distinction matters. Ketamine should not be presented as a cure for PTSD, and it is not appropriate for everyone. At Revitalizing Therapies, we discuss the off-label nature of ketamine therapy, potential benefits, risks, limitations, and alternatives during consultation so patients can make informed decisions.
A Care Model Built Around Safety, Trust, and Evaluation
Many patients who reach out to us have already tried multiple forms of care. Some are veterans or first responders. Others are survivors of accidents, assault, medical trauma, loss, or long-term stress. Some have lived with symptoms for years before realizing they may be connected to trauma.
Seeking a new option is not a failure. It is a sign that you are still looking for the right support.
Before ketamine therapy begins, our licensed clinical team reviews each patient’s medical history, psychiatric history, medications, prior treatments, and current symptoms. This process helps us determine whether ketamine may be appropriate and whether additional support, such as therapy or medication management, should be part of the plan.
For patients who feel nervous about the treatment experience, our guide on preparing for your first ketamine session can help explain what to expect. Sessions take place in a controlled clinical setting with monitoring and support from our team.
Ketamine-Assisted Psychotherapy and Trauma Work
For some patients with PTSD, ketamine may be considered alongside therapy rather than as a standalone intervention. This is where ketamine-assisted psychotherapy may be relevant.
Ketamine-assisted psychotherapy, or KAP, combines ketamine treatment with structured therapeutic support. The goal is not to force trauma processing or relive painful memories. Instead, therapy can help patients make sense of insights, emotions, or shifts that arise during and after ketamine sessions.
Emerging research suggests that ketamine may create a period of increased neuroplasticity after treatment. For some patients, that window may support therapeutic work, integration, and new ways of relating to traumatic memories. Revitalizing Therapies offers KAP for appropriate patients and discusses whether it makes sense based on each person’s clinical history and goals.
Patients who want to understand this approach more deeply can also read our related blog on how therapy changes when ketamine is in the room.
When PTSD Symptoms Show Up Years Later
Not everyone recognizes PTSD right away. Some people function for years after a traumatic event before symptoms become impossible to ignore. Others minimize what happened because they believe they “should be over it by now.”
Delayed or resurfacing trauma symptoms are not uncommon, and they do not mean someone is weak. They mean the nervous system may still be carrying something that deserves care.
If this sounds familiar, our blog on delayed-onset PTSD symptoms years later may be a helpful next read.
Frequently Asked Questions
Can ketamine therapy help with PTSD symptoms?
Clinical research suggests ketamine may reduce PTSD symptoms for some patients, particularly when other treatments have not provided enough relief. Ketamine’s use for PTSD is off-label, and individual responses vary, so Revitalizing Therapies evaluates each patient before recommending a plan.
How does ketamine for PTSD differ from ketamine for depression?
The medication may be the same, but the care plan can differ depending on symptoms, trauma history, therapy goals, and co-occurring conditions such as depression or anxiety. For PTSD, our team may also discuss whether ketamine-assisted psychotherapy could be appropriate.
How long do the effects of ketamine last for PTSD?
Duration of benefit varies. Some patients may notice changes after a treatment series, while others may need ongoing support or a different approach. Revitalizing Therapies builds follow-up recommendations around each patient’s response and clinical needs.
Will I need to stop my current medications before ketamine therapy?
Not necessarily. Many patients continue existing medications during ketamine treatment, but our clinical team reviews all medications during evaluation. Do not stop or change prescribed medications without guidance from your treating provider.
Is Revitalizing Therapies in Kissimmee experienced with trauma patients?
Revitalizing Therapies works with patients experiencing PTSD and trauma-related symptoms, including veterans, first responders, and survivors of many forms of trauma. Care is approached with sensitivity, privacy, and respect. To begin the conversation, contact our Kissimmee team at 321-483-2917.
Key Takeaways
- PTSD can affect memory, sleep, emotional regulation, relationships, and daily functioning.
- Ketamine therapy for PTSD is an off-label use and should be considered only after careful clinical evaluation.
- Research suggests ketamine may reduce PTSD symptom severity for some patients, but outcomes vary.
- Ketamine-assisted psychotherapy may help some patients integrate insights and therapeutic work after treatment.
- Revitalizing Therapies serves Kissimmee, Orlando, and surrounding Central Florida communities with trauma-informed, individualized care.
A Different Path Forward for PTSD Care in Kissimmee
PTSD does not have to be faced alone. When conventional care has not been enough, exploring another option with a qualified team may be a meaningful next step.
At Revitalizing Therapies, our Kissimmee team helps patients explore evidence-informed options with compassion, clinical care, and respect for each person’s story. Visit us at 100 E Dakin Ave, Kissimmee, FL 34741 or contact Revitalizing Therapies to schedule a free consultation.
References
VA National Center for PTSD. https://www.ptsd.va.gov/
National Institute of Mental Health: Post-Traumatic Stress Disorder. https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd
American Psychological Association: Clinical Practice Guideline for the Treatment of PTSD. https://www.apa.org/ptsd-guideline
Feder et al., 2014: Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1860851?
Feder et al., 2021: A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder. https://pubmed.ncbi.nlm.nih.gov/33397139/
About Michael McGowan
Michael McGowan, APRN, CRNA, serves as Clinical Director at Revitalizing Therapies. He brings extensive anesthesia experience across surgical, trauma stabilization, acute pain, and chronic pain settings. Ketamine infusions have played a significant role in his anesthetic practice in both hospital and clinical environments, and he brings years of experience administering ketamine safely and effectively. Michael is known for his patient-centered approach, clinical skill, and commitment to helping patients explore practical options for healing and hope.
Medical Disclaimer
The information provided in this blog is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Treatment outcomes vary by individual. Ketamine therapy for PTSD is an off-label use and may not be appropriate for everyone. Consult with a qualified healthcare provider before beginning any new treatment, and discuss whether this treatment is appropriate for your medical history, psychiatric history, current medications, and treatment goals.